Original document(16 pages)  中文版
    A preparation for nasal administration which comprises as an effective ingredient a prostaglandin derivative represented by Formula (I): wherein X is a halogen atom, R1 is a C3-10 cycloalkyl group, a C3-10 cycloalkyl group substituted with C1-4 alkyl group(s) or a C4-13 cycloalkylalkyl group, R2 is a hydrogen atom, a C1-10 alkyl group or a C3-10 cycloalkyl group, m is an integer of 0 to 3, and n is an integer of 1 to 4 or a pharmaceutically acceptable salt thereof and a water-soluble polymer.
Application Number
申请号
00816267 Application Date
申请日
2000.11.22
Title 名称 Pernasal preparation
Publication Number
公开号
1399551 Publication Date
公开日
2003.02.26
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/14;A61K31/5575;A61K47/32;A61K47/38;A61P25/20
Applicant(s) Name
申请人
Taisho Pharmaceutical Co., Ltd.
Address 地址
Inventor(s) Name 发明人 Ito Shusei;Yamada Kenji;Koda Ayumi et.al
Attorney & Agent 代理人 cao wen jiang jiancheng
More information 更  多  信  息


 Related patents information
Medicinal composition
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.